E4N-26576-82946
3 vaccinations
6 coded responses
36 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 070 / NJ
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Dose 1 — Pfizer-BioNTech
-
2021-04-03
Registered in v-safe
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-14
-
2021-04-21
Dose 2 — Pfizer-BioNTech
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-07-21
- 2021-10-20
-
2021-11-23
Dose 3 — Pfizer-BioNTech
- 2021-11-24
- 2021-11-25
-
2021-11-26
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Oedema peripheral — Feeling: Fair · Site: PainFree text: Some swelling/soreness in the armpit area of the arm which received the injection.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-27
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Oedema peripheral — Feeling: GoodFree text: Some swelling/pain in the armpit area of injection arm.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-28
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Oedema peripheral — Feeling: GoodFree text: Swelling has started to go down in armpit area of the injection arm. Little to no soreness now.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-29
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: GoodFree text: Some slight residual swelling in the armpit region of the injection arm. No pain.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-30
Survey response — day 7, dose 3MedDRA: Oedema peripheral — Feeling: GoodFree text: Minimal residual swelling in the armpit region of the injection arm. No pain.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-02-22
- 2022-05-24
-
2022-11-23
Survey response — 12 months, dose 3MedDRA: COVID-19, SARS-CoV-2 test negative, SARS-CoV-2 test positive — Feeling: GoodFree text: Had a Covid-19 occurrence. Tested positive on 11/1/22 and was still positive on 11/7/22. Had two consecutive negative test on 11/11/22 and 11/15/22.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-21 | Pfizer-BioNTech | |
| 3 | 2021-11-23 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Some swelling/soreness in the armpit area of the arm which received the injection.
Systemic reaction (other): Some swelling/pain in the armpit area of injection arm.
Systemic reaction (other): Swelling has started to go down in armpit area of the injection arm. Little to no soreness now.
Systemic reaction (other): Some slight residual swelling in the armpit region of the injection arm. No pain.
Release 10 — day 7, dose 3
Systemic reaction (other): Minimal residual swelling in the armpit region of the injection arm. No pain.
Release 12 — 12 months, dose 3
Symptoms: Had a Covid-19 occurrence. Tested positive on 11/1/22 and was still positive on 11/7/22. Had two consecutive negative test on 11/11/22 and 11/15/22.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release